Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia, especially androgenic, may increase cardiovascular risk, but more research is needed.

Early screening for Metabolic Syndrome in hair loss patients can help prevent heart disease.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

People with Alopecia Areata have a higher risk of heart-related health issues.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

People with psoriasis have more health problems, including autoimmune diseases, than those without it.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Oral minoxidil may help with pediatric hair disorders but has notable side effects.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Low-dose oral minoxidil does not significantly affect blood pressure in patients with hair loss and hypertension.

The drug combination was safe and showed promise in treating advanced tumors.

Skin tags in severely obese people may indicate higher blood pressure and diabetes risk.

Young Indians with coronary artery disease often have risk factors like smoking and central obesity, and cutaneous markers should be monitored for lifestyle changes.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Most patients with hard-to-treat high blood pressure can be managed effectively with various treatments, but no single treatment is perfect.

Consider systemic lupus erythematosus in patients with unexplained intracranial hypertension.

New treatments improved blood pressure control in patients with resistant hypertension.

Minoxidil effectively lowers blood pressure in patients with resistant hypertension.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Minoxidil significantly lowers blood pressure in patients with hard-to-treat hypertension, but can cause fluid retention and excessive hair growth.

Most patients with blistering skin disorders in South India had bullous pemphigoid and often had other conditions like hypertension and diabetes.

Long-term use of minoxidil for high blood pressure can delay kidney failure in some patients and improve kidney function in others with severe hypertension.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

Minoxidil effectively lowers blood pressure with few side effects.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Minoxidil lowers blood pressure without worsening lung pressure but can cause increased hair growth.

Minoxidil solution used on the scalp did not lower blood pressure in patients without hypertension.